Asfar S. Azmi
Abstracts by Asfar S. Azmi
Novel small-molecule CRM-1 inhibitor for GI cancer therapy.
Meeting: 2012 Gastrointestinal Cancers Symposium Abstract No: 245 First Author: Asfar S. Azmi
Category: Cancers of the Pancreas Small Bowel and Hepatobiliary Tract - Translational Research
Evaluation of a novel MDM-2 inhibitor with cisplatin/oxalipatin for the treatment of pancreatic cancer independent of p53 mutational status.
Meeting: 2010 ASCO Annual Meeting Abstract No: e13613 First Author: K. Almhanna
Category: Developmental Therapeutics - Experimental Therapeutics - Tyrosine Kinase Inhibitors
Virtual Meeting Presentations by Asfar S. Azmi :
Educational Book Manuscripts by Asfar S. Azmi :
Click on the title above to show these results.
Speaker pages are intended to connect and list abstracts, presentations and articles to authors of similar names, for your convenience. They are not intended to be a comprehensive list of authored work. ASCO sources currently utilized to create this list are meeting abstracts, virtual meeting presentations, and Educational Book articles. As additional sources are added the source list will be updated.
A speaker's name can be listed differently among various sources (i.e. J.P. Smith and John P. Smith). Authored work under a dissimilar name (nickname, abbreviations, or different spelling) will not be listed together.